ODDB.org: Open Drug Database

Grünenthal Pharma AG - Palexia retard 150 mg, Retardtabletten

Swissmedic Registration	62452	Sequence	03
Product name	Palexia retard 150 mg	Description	Retardtabletten
ATC-Classification	N02AX06	ATC-Description	Tapentadol
Introduction of Sequence	20.11.2013

Composition

tapentadolum 150 mg ut tapentadoli hydrochloridum, hypromellosum, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 3.185 mg, talcum, macrogolum 6000, propylenglycolum, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto.

Packungsbestandteile

Galenic Form

Delayed release tablets

Active Agent	Dose
	150 mg

BAG: Active Agent	Dose
	150 mg

Inactive agents	Dose	additional_information



		color.
		color.
Hypromellosum		Überzug
Lactose Monohydrate	3.185 mg
Macrogol	6000


Propylenglycol
Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
005	30 Tablet(s)	44.44	65.00	A+	SL	No
006	60 Tablet(s)	78.21	101.90	A+	SL	No

2025	©ywesee GmbH